The "Montreal TransMedTech Institute" in Biomedical Engineering and Medical Technology

在过去的几十年里，蒙雷亚尔理工学院建立了一个由生命科学和工程专家组成的跨学科小组，他们一直领导着生物医学工程和医疗技术领域的尖端技术的发展。这种可持续和成功的模式建立在与蒙特利尔地区的大型医院网络(圣贾斯汀分校、L的蒙特利尔大学、蒙特利尔心脏研究所、犹太综合医院)以及国际机构和行业合作伙伴建立和保持牢固联系的基础上，为复杂疾病提供可在医疗系统内测试和实施的健康创新解决方案。我们将利用这一变革性的大学-医院-行业一体化框架，通过创建蒙特利尔跨医学技术研究所来塑造医疗技术的未来，这是一个跨学科、跨领域和翻译的计划，旨在设计下一代诊断/预后，加拿大第一研究卓越基金的投资将使理工学院能够巩固和进一步发展一项杰出的综合生物医学工程研究计划的实施，该计划基于从健康问题到最有效的技术开发和实施的横向方法，以“活实验室”的方法进行。这个由患者、护理人员、工程师、临床医生、应用/基础研究科学家、学生、卫生系统利益相关者和政策制定者共同贡献的空间将从新医疗技术的开始到开发、实施和评估都得到实施，确保创新以减少技术转让障碍的方式满足实际需求。

Over the past decades, Polytechnique Montréal has established an interdisciplinary group of Life Sciences and Engineering experts who have been leading the development of cutting-edge technologies in the biomedical engineering and medical technology sectors. This sustainable and successful model is based on the creation and maintenance of strong ties with a large hospital network (CHU Sainte-Justine, Centre Hospitalier de l'Université de Montreal, Montreal Heart Institute, Jewish General Hospital) within the Montreal area, as well as with international institutional and industrial partners to provide health innovative solutions for complex diseases, that could be tested and implemented within the healthcare system.We will take advantage of this transformative integrated university-hospital-industry framework to shape the future of medical technologies through the creation of the Montreal TransMedTech Institute, a transdisciplinary, transversal and translational initiative aiming at engineering the next generation of diagnostic/prognostic, intervention/rehabilitation and medical technologies for a spectrum of complex diseases across all age groups.The Canada First Research Excellence Fund investment will enable Polytechnique to consolidate and further develop the implementation of an outstanding integrative biomedical engineering research initiative based on a transversal approach spanning from the health problem to the most efficient development and implementation of the technologies with a "living lab" approach. This co-creation space with contributions from patients, caregivers, engineers, clinicians, applied/fundamental research scientists, students, health system stakeholders, and policy makers will be implemented from the inception to the development, implementation and assessment of new medical technologies, ensuring that innovations meet real needs with reduced technology transfer obstacles.